Exagen Inc. (XGN) Earnings Call Analysis
NASDAQ · Healthcare · Diagnostics & Research
Next earnings call: 2026-08-04
(Q2 2026)
— full calendar
Earnings Reports
-
Exagen (XGN) Q1 2026: Ordering Clinicians Rise 15%, Underscoring Channel Penetration Momentum
May 11, 2026
-
XGN Q4 2025: Pharma Services Backlog Tops $4M, Raising Visibility on Diversification Strategy
March 10, 2026
-
Exagen (XGN) Q3 2025: ASP Rises 9% as Volume and Biomarker Innovation Drive Record Revenue
November 04, 2025
-
Exeget (XGN) Q2 2025: Per-Territory Revenue Jumps 50% as Commercial Execution Accelerates
August 05, 2025
-
Exeget (XGN) Q2 2025: Per-Territory Revenue Climbs 50%, Commercial Leverage Accelerates
August 05, 2025